Communiqués Scholar Rock Holding Corporation

Actions

SRRK

US80706P1030

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 17/07/2026			Varia. 5j.	Varia. 1 janv.
52,86 ^USD	+2,18 %		-6,79 %	+20,00 %

07/07	Traitements contre l'obésité : les laboratoires se bousculent pour conquérir un marché lucratif en pleine ébullition	RE
11/06	Médicaments anti-obésité : les laboratoires se bousculent sur un marché lucratif en pleine ébullition	RE

Communiqués

17/07	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
16/07	Scholar Rock to Report Second Quarter 2026 Financial Results on August 6, 2026	BU
22/06	Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD	BU
12/06	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
26/05	Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference	BU
20/05	Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference	BU
15/05	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
07/05	Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights	BU
29/04	Scholar Rock to Present at the BofA Securities 2026 Health Care Conference	BU
20/04	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
17/04	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
16/04	Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026	BU
31/03	Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)	BU
13/03	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
03/03	CORRECTING and REPLACING Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights	BU
18/02	Scholar Rock to Present at Upcoming Investor Conferences	BU
13/02	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
10/02	Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026	BU
19/01	Scholar Rock Reports New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)	AQ
16/01	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
12/01	Scholar Rock : SRRK Investor Presentation JPM 11Jan2025 FINAL SUBMITTED	PU
12/01	Scholar Rock Highlights 2026 Strategic Priorities	BU
05/01	Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference	BU
13/12	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
18/11	Scholar Rock to Present at Upcoming Investor Conferences	BU